2007;253:144 –53. 30. Polcher M, Braun M, Friedrichs N, Rudlowski C, Bercht E, Fimmers R, et al. Foxp3( +) cell in ﬁltration and granzyme B (+)/Foxp3( +) cell ratio are associated with outcome in neoadju- vant chemotherapy-treated ovarian carcinoma. Cancer Immunol Immunother. 2010;59:909 –19. 31. Milne K, Kobel M, Kalloger SE, Barnes RO, Gao D, Gilks CB, et al. Systematic analysis of immune in ﬁltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS ONE.